Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice

Arthritis and Rheumatism

Volumn 42, Issue 8, 1999, Pages 1635-1643

  Sasai, Mitsuko ^a   Saeki, Yukihiko ^a,b   Ohshima, Shiro ^a   Nishioka, Katsuhiro ^a   Mima, Toru ^a   Tanaka, Toshio ^b   Katada, Yoshinori ^c   Yoshizaki, Kazuyuki ^d   Suemura, Masaki ^b   Kishimoto, Tadamitsu ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; INTERLEUKIN 6;

ADOLESCENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE EROSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMORAL IMMUNITY; LYMPH NODE CELL; MOUSE; NONHUMAN; ONSET AGE; OSTEOPENIA; PRIORITY JOURNAL; TH2 CELL;

ANIMALS; ANTIBODIES; ARTHRITIS, EXPERIMENTAL; BONE DISEASES, METABOLIC; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; LYMPH NODES; MICE; MICE, INBRED DBA; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH2 CELLS;

EID: 0033503152     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q     Document Type: Article

References (39)

1. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
2. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
3. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992;258:593-7.
4. Akira S, Kishimoto T. IL-6 and NF-IL-6 in acute-phase response and viral infection. Immunol Rev 1992;127:25-50.
5. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988;18:1797-801.
6. Houssiau FA, Devogelaer J-P, van Damme J, de Deuxchaisnes CN, van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-8.
7. Firestein GS, Alvaro-Garcia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
8. Mihara M, Moriya Y, Kishimoto T, Ohsugi Y. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 1995;34:321-5.
9. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 1993;90: 11924-8.
10. Wendling D, Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 1993;20:259-62.
11. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
12. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146: 857-68.
13. Stuart JM, Townes AS, Kang AH. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest 1982;69:673-83.
14. Stuart JM, Townes AS, Kang AH. Collagen autoimmune arthritis. Annu Rev Immunol 1984;2:199-218.
15. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 1992;89:9784-8.
16. Mori L, Iselin S, de Libero G, Lesslauer W. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG-treated and TNFR1-deficient mice. J Immunol 1996;157:3178-82.
17. Joosten LAB, Helsen MMA, van de Loo FAJ, van den Berg WB. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra. Arthritis Rheum 1996;39:797-809.
18. Ohshima S, Saeki Y, Mima T, Sasai M, Nishioka K, Nomura S, et al. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci U S A 1998;95:8222-6.
19. Brackertz D, Mitchell GF, Mackay IR. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 1977;20:841-50.
20. Maeda M, Cooke TDV. Destruction of rabbit knee hyaline cartilage associated with surface antigen-antibody interaction during the arthus reaction of antigen-induced arthritis. Clin Orthop Rel Res 1983;190:287-91.
21. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339-42.
22. Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154:688-700.
23. Inoue K, Motonaga A, Suzuka H, Yoshifusa H, Fujisawa H, Nishimura T, et al. Effect of etodolac on type-II collagen-induced arthritis in mice. Agents Actions 1993;39:187-94.
24. + T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 1996;156:4520-6.
25. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996;26:1511-8.
26. Takai Y, Seki N, Senoh H, Yokota T, Lee F, Hamaoka T, et al. Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis. Arthritis Rheum 1989;32:594-600.
27. Mihara M, Ikuta M, Koishihara Y, Ohsugi Y. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis. Eur J Immunol 1991;21:2327-31.
28. Van de Loo FAJ, Joosten LAB, van Lent PLEM. Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor α, and intcrleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen-and zymosan-induced arthritis. Arthritis Rheum 1995;38:164-72.
29. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, et al. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998;187:461-8.
30. Van den Berg WB, Joosten LAB, Helsen M, van de Loo FAJ. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol 1994;95:237-43.
31. Miossec P, van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum 1997;40:2105-15.
32. Miltenburg AMM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992;35:603-10.
33. Apparailly F, Verwaerde C, Jacquet C, Auriant C, Sany J, Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998;160:5213-20.
34. Joosten LAB, Lubberts E, Durez P, Helsen MMA, Jacobs MJM, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249-60.
35. Horsfall AC, Butler DM, Marinova L, Warden PJ, Williams RO, Maini RN, et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 1997;159:5687-96.
36. + T helper cell 1 development in interleukin-6 deficient mice infected with Candida albicans. J Exp Med 1996;183:1345-55.
37. + T cells. J Exp Med 1997;185:461-9.
38. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SHE. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 1997;65:4843-9.
39. Brewer JM, Conacher M, Gaffney M, Douglas M, Bluethmann H, Alexander J. Neither interleukin-6 nor signalling via tumor necrosis factor receptor-1 contribute to the adjuvant activity of Alum and Freund's adjuvant. Immunology 1998;93:41-8.